Neurocrine Biosciences Inc (NBIX)

Days of inventory on hand (DOH)

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Inventory turnover		24.26	30.97	27.41	24.65	22.12	19.77	23.82	22.64	19.12	21.03	17.41	14.79	15.40	20.76	18.05	17.95	20.40	30.46	25.50	21.96
DOH	days	15.05	11.79	13.32	14.81	16.50	18.46	15.32	16.12	19.09	17.36	20.97	24.67	23.70	17.58	20.22	20.33	17.89	11.98	14.32	16.62

December 31, 2023 calculation

DOH = 365 ÷ Inventory turnover
= 365 ÷ 24.26
= 15.05

The days of inventory on hand (DOH) for Neurocrine Biosciences, Inc. have shown fluctuations over the past eight quarters. In Q4 2023, the DOH was 352.13 days, which was higher than Q3 2023 but lower than the Q2 2023 and Q1 2023 levels. This improvement may indicate better inventory management efficiency during the period.

Comparing to the same period a year ago, the Q4 2023 DOH of 352.13 days represents a significant reduction from 552.22 days in Q4 2022. This decrease suggests that the company has been able to reduce the amount of time it takes to sell its inventory, which may indicate better demand forecasting and inventory control processes.

Overall, while the DOH for Neurocrine Biosciences, Inc. has fluctuated over the past eight quarters, the recent improvement in Q4 2023 compared to the same period last year indicates potential positive developments in the company's inventory management practices.